Cargando…

Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer

BACKGROUND: Circulating tumor cells (CTCs) can be clustered into three subtypes according to epithelial-mesenchymal transition (EMT) markers: CTCs with epithelial markers (E-CTCs), CTCs with mesenchymal markers (M-CTCs), and CTCs with both markers (E&M-CTCs). CTC detection has clinical implicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Sha-Sha, Mao, Chun-Guo, Feng, Yong-Geng, Jiang, Bin, Tao, Shao-Lin, Tan, Qun-You, Deng, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Clinical and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058682/ https://www.ncbi.nlm.nih.gov/pubmed/33969055 http://dx.doi.org/10.12998/wjcc.v9.i12.2721

Ejemplares similares

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

Links between cancer stem cells and epithelial–mesenchymal transition
por: Wang, Sha-sha, et al.
Publicado: (2015)

CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition
por: Kapur, Neeraj, et al.
Publicado: (2016)

Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
por: Ho, Gwo Yaw, et al.
Publicado: (2022)

BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma
por: Mao, Chun-Guo, et al.
Publicado: (2021)

Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: a meta-analysis and system review
por: Jiang, Sha-Sha, et al.
Publicado: (2019)

Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells
por: Yang, Q, et al.
Publicado: (2014)

High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition
por: Jiang, Shasha, et al.
Publicado: (2020)

E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines
por: Lombaerts, M, et al.
Publicado: (2006)

Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial–mesenchymal transition and poor overall survival
por: Kucia-Tran, Justyna A, et al.
Publicado: (2016)

In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines
por: Adhim, Z, et al.
Publicado: (2011)

Intermediate cell states in epithelial-to-mesenchymal transition
por: Sha, Yutong, et al.
Publicado: (2019)

The Role of Carcinogenesis-Related Biomarkers in the Wnt Pathway and Their Effects on Epithelial–Mesenchymal Transition (EMT) in Oral Squamous Cell Carcinoma
por: Bai, Yunpeng, et al.
Publicado: (2020)

Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model
por: Bhardwaj, A, et al.
Publicado: (2014)

Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition
por: Byrne, N M, et al.
Publicado: (2016)

Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition
por: Duran, George E, et al.
Publicado: (2017)

FAK regulates epithelial-mesenchymal transition in adenomyosis
por: Zheng, Dexuan, et al.
Publicado: (2018)

Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells
por: Wang, Yihua, et al.
Publicado: (2019)

P130cas is required for TGF-β1-mediated epithelial-mesenchymal transition in lung cancer
por: DENG, BO, et al.
Publicado: (2014)

P130cas is required for TGF-β1-mediated epithelial-mesenchymal transition in lung cancer
por: Deng, Bo, et al.
Publicado: (2020)

Relaxin inhibits renal fibrosis and the epithelial-to-mesenchymal transition via the Wnt/β-catenin signaling pathway
por: Feiteng, Chen, et al.
Publicado: (2022)

Identification of an epithelial-mesenchymal transition-related lncRNA prognostic signature for patients with glioblastoma
por: Yang, XinJie, et al.
Publicado: (2021)

BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A
por: Mao, Chun‐guo, et al.
Publicado: (2020)

Circulating miRNAs Related to Epithelial–Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis
por: Zubrzycka, Anna, et al.
Publicado: (2021)

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
por: Kölbl, Alexandra C., et al.
Publicado: (2016)

Concise Review: Aggressive Colorectal Cancer: Role of Epithelial Cell Adhesion Molecule in Cancer Stem Cells and Epithelial‐to‐Mesenchymal Transition
por: Boesch, Maximilian, et al.
Publicado: (2018)

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
por: Kallergi, Galatea, et al.
Publicado: (2011)

Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells of Breast Cancer Patients
por: Krawczyk, Natalia, et al.
Publicado: (2014)

Inference and multiscale model of epithelial-to-mesenchymal transition via single-cell transcriptomic data
por: Sha, Yutong, et al.
Publicado: (2020)

miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells
por: Qin, Haifeng, et al.
Publicado: (2015)

Aspirin inhibit platelet-induced epithelial-to-mesenchymal transition of circulating tumor cells (Review)
por: LOU, XIAO-LIANG, et al.
Publicado: (2014)

FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response
por: Velalopoulou, Anastasia, et al.
Publicado: (2021)

Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
por: Li, Y-M, et al.
Publicado: (2013)

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2012)

Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients
por: Zhang, Ruiyun, et al.
Publicado: (2020)

Zyxin inhibits the epithelial–mesenchymal transition process in gastric cancer by upregulating SIRT1
por: Lou, Jing, et al.
Publicado: (2023)

The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers
por: Cavallari, Ilaria, et al.
Publicado: (2021)

Role of Ferroptosis in Regulating the Epithelial–Mesenchymal Transition in Pulmonary Fibrosis
por: Ling, Hong, et al.
Publicado: (2023)

Analysis of epithelial–mesenchymal transition markers in psoriatic epidermal keratinocytes
por: Man, Xiao-Yong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hcbkqse1tmgj2t73f5hl7jok9r